Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SU101 small molecule inhibitor of the PDGF receptor data

SUGN announced that 6 of 12 evaluable patients in an uncontrolled Phase II trial of

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE